DuPont de Nemours, Inc.

NYSE:DD Rapport sur les actions

Capitalisation boursière : US$19.4b

DuPont de Nemours Gestion

Gestion contrôle des critères 3/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Lori Koch

Directeur général

US$16.1m

Rémunération totale

Pourcentage du salaire du PDG7.70%
Durée du mandat du directeur général2yrs
Propriété du PDG0.09%
Durée moyenne d'occupation des postes de direction1.4yrs
Durée moyenne du mandat des membres du conseil d'administration6.8yrs

Mises à jour récentes de la gestion

Recent updates

Mise à jour du récit Jun 13

DD: Water Infrastructure Contracts And 2026 Guidance Will Support Further Upside

Analysts have nudged their average price target for DuPont de Nemours higher from $56.13 to about $57.07, reflecting updated assumptions for slightly different discount rates, revenue growth, profit margins, and future P/E levels. What's in the News DuPont's MemCor MBR system was selected for a major upgrade at the Riverstone Water Resource Recovery Facility in Sydney, supporting higher wastewater treatment capacity and long term environmental protection in a fast growing region.
Mise à jour du récit May 30

DD: Guidance Reaffirmation And Buybacks Will Support Future Upside Potential

Analysts have nudged their price target for DuPont de Nemours slightly higher to $64.00, citing updated assumptions for revenue growth, profit margins and future P/E that refine rather than overhaul their outlook on the stock. What's in the News Shareholders approved an amendment to the Certificate of Incorporation to allow a reverse stock split between 1-for-2 and 1-for-4, along with a corresponding reduction in authorized common shares at the May 21, 2026 AGM (Changes in Company Bylaws/Rules).
Seeking Alpha May 27

I See A Better DuPont, Not A Bargain

Summary DuPont de Nemours, Inc. is a leading science and materials company supplying specialized products to manufacturers, not direct consumers. DD recently sold its Aramids division, including Kevlar and Nomex, for $1.8 billion, streamlining its portfolio. AI and data center demand are driving significant growth in DD's microelectronics segment, making it a core business focus. After years of underperformance, DD shares have begun to outperform the S&P 500, supported by a reverse split and reaffirmed 2026 guidance. Read the full article on Seeking Alpha
Mise à jour du récit May 07

DD: PFAS Legal Overhang Will Set Up Future Buyback And Guidance Upside

Analysts have slightly adjusted their 12 month price target for DuPont de Nemours to about $63.81 from $64.00. This reflects updated assumptions for revenue growth, profit margins and future P/E expectations.
Mise à jour du récit Apr 23

DD: PFAS Legal Overhang Will Set Up Future Water And Healthcare Upside

Analysts reaffirm a $64.00 price target on DuPont de Nemours, citing modest adjustments to the discount rate, revenue growth, profit margin, and future P/E assumptions rather than a shift in their overall view of the shares. What's in the News DuPont plans to seek shareholder approval in May 2026 for a potential reverse stock split of its common stock at a ratio between 1 for 2 and 1 for 4, with the board retaining discretion on timing and whether to proceed.
Mise à jour du récit Apr 08

DD: Share Actions And Water Solutions Expansion Will Shape A Measured Outlook

Analysts have adjusted the price target for DuPont de Nemours from $44 to $50, reflecting updated assumptions around revenue growth, profit margins, a revised discount rate, and slightly lower future P/E expectations. What's in the News DuPont plans to seek shareholder approval to amend its certificate of incorporation to allow a reverse stock split of common shares at a ratio between 1-for-2 and 1-for-4, with the exact ratio and timing at the discretion of the board.
Mise à jour du récit Mar 24

DD: PFAS Legal Overhang Will Set Up Future Product Expansion Upside

Analysts have raised their price target on DuPont de Nemours from about $55 to $64, citing updated assumptions for revenue growth, profit margins, and a lower discount rate that together support a reduced future P/E estimate. What's in the News The company plans to seek shareholder approval for a reverse stock split in a range of 1 for 2 to 1 for 4 at the May 21, 2026 annual meeting.
Mise à jour du récit Mar 09

DD: Water Technology Expansion And 2026 Guidance Will Support Future Upside

Analysts have kept their $56.13 price target for DuPont de Nemours unchanged, citing largely steady assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E. Together, these factors signal a consistent outlook on the stock's risk and return profile.
Mise à jour du récit Feb 23

DD: New Guidance And Product Pipeline Will Support Future Upside

Analysts have raised their price target on DuPont de Nemours from about $49.19 to $56.13, citing updated assumptions for revenue growth, profit margins, discount rate, and future P/E that they view as better reflecting the company’s potential risk and return profile. What's in the News Issued new earnings guidance for the first quarter of 2026, with expected net sales of $1,670 million.
Article d’analyse Feb 17

There May Be Reason For Hope In DuPont de Nemours' (NYSE:DD) Disappointing Earnings

The market was pleased with the recent earnings report from DuPont de Nemours, Inc. ( NYSE:DD ), despite the profit...
Mise à jour du récit Feb 09

DD: Legal PFAS Overhang Will Set Up Future Product Expansion Upside

Analysts have revised their price target for DuPont de Nemours from about US$113 to roughly US$55, reflecting updated views on fair value, a higher discount rate, softer revenue growth expectations, slightly lower profit margins, and a higher assumed future P/E multiple. What's in the News DuPont launched the FilmTec MXP RO-8038-FF reverse osmosis element for dairy processors, designed as a drop in option for mesh wrapped systems that targets around 5% higher active membrane area and up to 50% higher productivity compared with conventional mesh wrapped elements, while aiming to reduce wastewater and maintain existing plant setups (Product related announcement).
Mise à jour du récit Jan 26

DD: Share Buybacks Will Drive Future Upside As New Plant Expands Capacity

Analysts have raised their price target for DuPont de Nemours from US$47.31 to US$49.19, citing updated assumptions around discount rates, revenue trends, profit margins and a revised future P/E outlook. What's in the News A Montana federal judge denied motions to dismiss a class-action lawsuit related to alleged PFAS risks in firefighter turnout gear that names DuPont alongside other manufacturers, allowing claims under multiple legal theories, including RICO, to proceed for now (Lawsuits & Legal Issues).
Mise à jour du récit Jan 12

DD: Share Returns And Qnity Separation Will Frame A Measured Forward Outlook

Analysts have maintained their price target for DuPont de Nemours at $44.00, with this reaffirmed view supported by updated assumptions of a smaller revenue decline, higher profit margins, and a lower future P/E multiple. What's in the News A Montana federal judge denied motions to dismiss a class-action lawsuit alleging DuPont and other manufacturers concealed health risks linked to PFAS chemicals in firefighter turnout gear, allowing RICO and other claims to proceed for now (Lawsuits & Legal Issues).
Mise à jour du récit Dec 27

DD: Share Buybacks Will Drive Future Upside As New China Plant Expands Capacity

Narrative Update on DuPont de Nemours Analysts have modestly raised their average price target on DuPont de Nemours by approximately $0.06, reflecting slightly improved views on the company’s discount rate and profit margin outlook, despite marginally weaker revenue growth expectations. What's in the News Begins construction of a new MOLYKOTE specialty lubricants plant in Zhangjiagang, China, expanding global capacity and targeting fast growing demand across transportation, industrial, energy, and electronics markets, with operations expected to start in early 2027 (Key Developments) The board authorizes a share repurchase program of up to $2 billion, indicating a focus on capital returns to shareholders (Key Developments) Issues updated 2025 guidance, trimming full year net sales expectations to $6.84 billion and guiding fourth quarter net sales of about $1.685 billion (Key Developments) Declares a quarterly dividend of $0.20 per share, payable December 15, 2025, and also approves a pro rata special dividend to spin off Qnity to existing shareholders on November 1, 2025 (Key Developments) Introduces new safety and industrial products, including Tyvek APX high breathability chemical protective garments and IntegraTec XTP 100 IG ultrafiltration modules, together with new comfort and mobility testing protocols for soft ballistic body armor (Key Developments) Valuation Changes Fair Value: risen slightly from $47.25 to about $47.31 per share, indicating a marginally higher intrinsic value estimate.
Mise à jour du récit Dec 13

DD: Share Returns And Qnity Separation Will Shape A Balanced Outlook

Narrative Update Analysts have cut their average 12 month price target on DuPont de Nemours to approximately 44 dollars from about 62 dollars. This reflects reduced expectations for revenue growth and profit margins, along with a higher assumed valuation multiple and discount rate.
Mise à jour du récit Nov 29

DD: Share Repurchase Plan Will Drive Upside as New Plant Breaks Ground

Analysts have revised their price target for DuPont de Nemours downward by $6.00 to $47.25, citing recent adjustments in growth and profitability expectations. What's in the News DuPont broke ground on a new MOLYKOTE specialty lubricants manufacturing plant in Zhangjiagang, China.
Mise à jour du récit Nov 15

DD: Future Share Buybacks Will Unlock Value Amid Uncertainty

Analysts have revised their price target for DuPont de Nemours sharply downward from $93.69 to $53.25, citing updated financial forecasts and increased market uncertainty. What's in the News DuPont unveiled Tyvek APX, a new disposable chemical garment fabric designed for increased comfort and breathability without compromising protection.
Article d’analyse Nov 09

DuPont de Nemours (NYSE:DD) Is Paying Out Less In Dividends Than Last Year

DuPont de Nemours, Inc. ( NYSE:DD ) is reducing its dividend from last year's comparable payment to $0.20 on the 15th...
Mise à jour du récit Nov 01

DD: Qnity Separation And Water Solutions Will Drive Outperformance

Analysts have slightly reduced their price target for DuPont de Nemours from $93.81 to $93.69. This change reflects modest adjustments in growth forecasts and profitability expectations.
Mise à jour du récit Oct 17

Electronics, Healthcare And Water Will Drive Future Success

Analysts have raised their price target for DuPont de Nemours from $92.67 to $93.81. They cite modest improvements in profit margin expectations and slightly adjusted growth assumptions as the reasons for this change.
Mise à jour du récit Sep 24

Electronics, Healthcare And Water Will Drive Future Success

Despite a reduced revenue growth outlook, improved net profit margins have driven the consensus analyst price target for DuPont de Nemours up from $89.31 to $92.67. What's in the News DuPont is actively pursuing strategic bolt-on acquisitions, focusing on enhancing capabilities and targeting growth opportunities, while maintaining a balanced approach between buybacks and M&A.
Mise à jour du récit Sep 04

Electronics, Healthcare And Water Will Drive Future Success

As DuPont de Nemours’ revenue growth and discount rate forecasts remained steady, analysts kept their price target unchanged at $89.31. What's in the News Analyst/Investor Day announced.
Article d’analyse Jul 23

Is DuPont de Nemours, Inc. (NYSE:DD) Trading At A 47% Discount?

Key Insights Using the 2 Stage Free Cash Flow to Equity, DuPont de Nemours fair value estimate is US$146 DuPont de...
Seeking Alpha Apr 07

DuPont: Upgrading To Hold Amid China Risks

Summary DuPont shares have underperformed the broader market since my Sell recommendation was published. A new antitrust probe by the Chinese government is a negative but the stock's valuation reflects this risk. I believe it will be difficult for the company to meet consensus EPS estimates given the macroeconomic backdrop. I up upgrading the stock to Hold as a view the risk-reward more balanced for the stock now than was previously the case. Read the full article on Seeking Alpha

Analyse de la rémunération des PDG

Comment la rémunération de Lori Koch a-t-elle évolué par rapport aux bénéfices de DuPont de Nemours?
DateRémunération totaleSalaireBénéfices de l'entreprise
Mar 31 2026n/an/a

US$132m

Dec 31 2025US$16mUS$1m

US$57m

Sep 30 2025n/an/a

US$479m

Jun 30 2025n/an/a

US$630m

Mar 31 2025n/an/a

-US$234m

Dec 31 2024US$13mUS$1m

-US$131m

Sep 30 2024n/an/a

US$421m

Jun 30 2024n/an/a

US$260m

Mar 31 2024n/an/a

US$404m

Dec 31 2023US$4mUS$750k

-US$101m

Sep 30 2023n/an/a

US$895m

Jun 30 2023n/an/a

US$963m

Mar 31 2023n/an/a

US$1b

Dec 31 2022US$5mUS$742k

US$1b

Sep 30 2022n/an/a

US$1b

Jun 30 2022n/an/a

US$960m

Mar 31 2022n/an/a

US$989m

Dec 31 2021US$5mUS$700k

US$1b

Sep 30 2021n/an/a

US$1b

Jun 30 2021n/an/a

US$1b

Mar 31 2021n/an/a

-US$1b

Dec 31 2020US$4mUS$647k

-US$1b

Rémunération vs marché: La rémunération totale de Lori ($USD 16.13M ) est dans la moyenne des entreprises de taille similaire sur le marché US ($USD 14.60M ).

Rémunération et revenus: La rémunération de Lori a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.


PDG

Lori Koch (51 yo)

2yrs
Titularisation
US$16,134,250
Compensation

Ms. Lori D. Koch serves as Chief Executive Officer at DuPont Ventures. Ms. Lori is responsible for overseeing the strategic direction of the company to accelerate growth, unlock value, advance innovation,...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Lori Koch
CEO & Director2yrsUS$16.13m0.085%
$ 16.6m
Antonella Franzen
Senior VP & CFO2yrsUS$4.94m0.017%
$ 3.3m
Erik Hoover
Senior VP & General Counselno dataUS$3.53m0.029%
$ 5.6m
Christopher Raia
Chief Human Resources Officer5.3yrsUS$2.92m0.021%
$ 4.1m
Jeroen Bloemhard
President of Healthcare & Water Technologiesless than a yearUS$2.25m0.0010%
$ 200.1k
David Koch
Chief Operations & Engineering Officer1.4yrspas de donnéespas de données
Madeleine Barber
VP of Taxless than a yearpas de données0.0014%
$ 270.0k
Marty DeGroot
Chief Technology Officer1.4yrspas de donnéespas de données
Matthew Abbott
SVP, Chief Information Officer & Chief Procurement Officerless than a yearpas de données0.00047%
$ 91.3k
Ann Giancristoforo
VP of Investor Relationsno datapas de donnéespas de données
Beth Ferreira
President of Diversified Industrialsless than a yearpas de donnéespas de données
Sasha Down
Chief Strategy Officer1.4yrspas de donnéespas de données
1.4yrs
Durée moyenne de l'emploi
52.5yo
Âge moyen

Gestion expérimentée: L'équipe de direction de DD n'est pas considérée comme expérimentée (ancienneté moyenne 1.4 ans), ce qui suggère une nouvelle équipe.


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Lori Koch
CEO & Director2yrsUS$16.13m0.085%
$ 16.6m
Alexander Cutler
Lead Independent Director8.8yrsUS$412.42k0.00077%
$ 149.6k
Edward Breen
Non-Executive Chairman8.8yrsUS$7.67m0.069%
$ 13.3m
James Lico
Independent Director2.1yrsUS$320.32k0.0027%
$ 520.5k
Eleuthere du Pont
Independent Director7yrsUS$333.22k0.00047%
$ 91.3k
Ruby Chandy
Independent Director7yrsUS$340.32k0.00025%
$ 48.6k
Donald Macpherson
Independent Directorless than a yearpas de données0.0014%
$ 281.6k
Kurt McMaken
Independent Director1.3yrsUS$393.19k0.0020%
$ 396.2k
Amy Brady
Independent Director6.7yrsUS$320.32k0.00017%
$ 33.0k
Frederick Lowery
Independent Director7yrsUS$345.32k0.00025%
$ 48.6k
6.8yrs
Durée moyenne de l'emploi
59yo
Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de DD sont considérés comme expérimentés (ancienneté moyenne 6.8 ans).


Analyse de l'entreprise et données financières

DonnéesDernière mise à jour (heure UTC)
Analyse de l'entreprise2026/06/18 21:39
Cours de l'action en fin de journée2026/06/18 00:00
Les revenus2026/03/31
Revenus annuels2025/12/31

Sources de données

Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.

PaquetDonnéesCadre temporelExemple de source américaine *
Finances de l'entreprise10 ans
  • Compte de résultat
  • Tableau des flux de trésorerie
  • Bilan
Estimations consensuelles des analystes+3 ans
  • Prévisions financières
  • Objectifs de prix des analystes
Prix du marché30 ans
  • Cours des actions
  • Dividendes, scissions et actions
Propriété10 ans
  • Actionnaires principaux
  • Délits d'initiés
Gestion10 ans
  • L'équipe dirigeante
  • Conseil d'administration
Principaux développements10 ans
  • Annonces de l'entreprise

* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.

Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.

Modèle d'analyse et flocon de neige

Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.

Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.

Indicateurs de l'industrie et du secteur

Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.

Sources des analystes

DuPont de Nemours, Inc. est couverte par 35 analystes. 15 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.

AnalysteInstitution
William SeleskyArgus Research Company
Patrick Duffy FischerBarclays
Michael LeitheadBarclays